Expression of survivin and its splice variants in gastric cancer

Abstract

Survivin variants specific real time quantitative RT-PCR was developed to analyze their expression in 53 paired cancer and para-cancerous tissues, and the expression of the wild-type survivin protein was detected by immunohistochemistry. The results showed that survivin mRNA and protein were expressed in gastric cancer and para-cancerous tissues. The survivin-2B was dominantly expressed in para-cancerous tissues, whereas the survivin-ΔEx3 was more frequently detected in cancer tissues. The positive rate of survivin-2a was 100% in both cancer and para-cancerous tissues, but its relative transcript expression level was not significantly increased in cancer tissues in comparison with para-cancerous tissues. The correlation analysis revealed that the expression of survivin-2a mRNA was significantly associated with that of total survivin (r_s=0.4178, P=0.0018), whereas inversely to that of survivin-ΔEX3 (r_s=−0.4506, P=0.0007). It was suggested that survivin-2a may act as an antagonist of survivin-ΔEX3. The balance between antiapoptotic survivin iso-forms and nonantiapoptotic ones may play an important role in tumorigenesis and tumor progression. Promising value is hinted to analyze survivin and its variants in tumor early diagnosis and distinguishing malignant tumors from benign ones.

Keywords

survivin / splice variants / real-time PCR

References

[1] AmbrosiniG., AdidaC., AltieriD. C.. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med, 1997, 3: 917-921

[2] AmbrosiniG., AdidaC., SirugoG., et al.. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem, 1998, 273: 11 177-11 182

[3] AltieriD. C., MarchisioC.. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest, 1999, 79: 1327-1333

[4] RyanB., O’DonovanN., BrowneB., et al.. Expression of survivin and its splice variants survivin-2B and survivin-ΔEX3 in breast cancer. Br J Cancer, 2005, 92: 120-124

[5] MahotkaC., WenzelM., SpringerE., et al.. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res, 1999, 59: 6097-6102

[6] ConwayE. M., PollefeytS., CornelissenJ., et al.. Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood, 2000, 95: 1435-1442

[7] BadranA., YoshidaA., IshikawaK., et al.. Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem Biophys Res Commun, 2004, 314: 902-907

[8] MirzaA., McGuirkM., HockenberryT. N., et al.. Human survivin is negatively regulated by wild-type p53 and participate in p53-dependent apoptotic pathway. Oncogene, 2002, 21: 2613-2622

[9] KriegA., MahotkaC., KriegT., et al.. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumor progression. Br J Cancer, 2002, 86: 737-743

[10] MengH., LuC. D., MabuchiH., et al.. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Letters, 2004, 216: 147-155

[11] TellmannG.. The E-Method: a highly accurate technique for gene-expression analysis. Nature Methods, 2006, 3: i-ii

[12] SpanP. N., Tjan-HeijnenV. C., HeuvelJ. J., et al.. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?. Clin Chem, 2006, 52(9): 1693-1700

[13] ChiouS. K., MoonW. S., JonesM. K., et al.. Survivin expression in the stomach: implication for mucosal integrity and protection. Biochem Biophys Res Commun, 2003, 305(2): 374-379

[14] CaldasH., JiangY., HollowayM. P., et al.. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene, 2005, 24: 1994-2007

[15] NotonE. A., ColnaghiR., TateS., et al.. Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis. J Biol Chem, 2006, 281(2): 1286-1295

[16] CaldasH., HonseyL. E., AlturaR. A.. Survivin 2α: a novel Survivin splice variant expressed in human malignancies. Mol Cancer, 2005, 4: 11

[17] TanakaK., IwamotoS., GonG., et al.. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res, 2000, 6: 127-134

[18] RohayemJ., DiestelkoetterP., WeigleB., et al.. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res, 2000, 60: 1815-1817

[19] IslamA., KageyamaH., TakadaN., et al.. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene, 2000, 19: 617-623